Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD.

Provenzano R, Besarab A, Sun CH, Diamond SA, Durham JH, Cangiano JL, Aiello JR, Novak JE, Lee T, Leong R, Roberts BK, Saikali KG, Hemmerich S, Szczech LA, Yu KH, Neff TB.

Clin J Am Soc Nephrol. 2016 Jun 6;11(6):982-91. doi: 10.2215/CJN.06890615. Epub 2016 Apr 19.

2.

Intradialytic Hypertension / Hypotension and Mortality in San Juan, Puerto Rico.

Diaz HJ, Bryan J, Arraut JC, Betancourt J, Morales CM, Cangiano JL.

Bol Asoc Med P R. 2016;108(1):75-8.

PMID:
29193923
3.

Analysis of clinical characteristics of dialysis patients at the University Hospital.

Cintrón Rosa FB, Soto Hernández E, Rivera Valentín A, Díaz Rodríguez HJ, Arroyo Soto JM, Delgado Garrastegui ÁF, Ocasio Meléndez IE, Ortiz Kidd E, Cangiano JL.

Bol Asoc Med P R. 2016;108(2):81-3.

PMID:
29172371
4.

Longitudinal Observations on the Mineral Metabolism of Dialysis Patients at the University Hospital.

Colón C, Watts E, Rebollo NP, Ocasio I, Cangiano JL.

P R Health Sci J. 2015 Jun;34(2):93-7.

PMID:
26061060
5.

Anemia management among hemodyalisis patients at the University Hospital in Puerto Rico.

Ocasio HE, Diaz H, Cangiano JL, Báez R, Suárez E.

Bol Asoc Med P R. 2014;106(2):9-12.

PMID:
25065044
6.

Predisposing factors for acute kidney injury in Hispanic patients treated with diuretics for decompensated heart failure.

Ricci F, Ramírez T, Marmorato R, Vega J, Pagán P, López JE, Soto-Salgado M, Cangiano JL.

P R Health Sci J. 2013 Jun;32(2):63-7.

PMID:
23781621
7.

Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Macdougall IC, Provenzano R, Sharma A, Spinowitz BS, Schmidt RJ, Pergola PE, Zabaneh RI, Tong-Starksen S, Mayo MR, Tang H, Polu KR, Duliege AM, Fishbane S; PEARL Study Groups.

N Engl J Med. 2013 Jan 24;368(4):320-32. doi: 10.1056/NEJMoa1203166.

8.

Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.

Crespo MJ, Cangiano JL, Altieri PI, Escobales N.

J Cardiovasc Pharmacol. 2012 Jun;59(6):547-52. doi: 10.1097/FJC.0b013e31824e5273.

PMID:
22370958
9.

Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial.

Lewis EJ, Lewis JB, Greene T, Hunsicker LG, Berl T, Pohl MA, de Zeeuw D, Heerspink HL, Rohde RD, Atkins RC, Reutens AT, Packham DK, Raz I; Collaborative Study Group.

Am J Kidney Dis. 2011 Nov;58(5):729-36. doi: 10.1053/j.ajkd.2011.06.020. Epub 2011 Aug 26. Erratum in: Am J Kidney Dis. 2012 Feb;59(2):318.

PMID:
21872376
10.

General concepts in the management of a kidney transplant.

Ortiz-Heredia L, Cangiano JL.

Bol Asoc Med P R. 2011 Jul-Sep;103(3):52-6.

PMID:
23210335
11.

Kidney biopsy findings as prognostic factors of renal outcome in a case of ANCA-associated glomerulonephritis.

Meza-Venencia V, Ortiz-Kidd E, Cangiano JL.

Bol Asoc Med P R. 2011 Jul-Sep;103(3):25-8.

PMID:
23210329
12.

Registry of kidney biopsy in a single center in Puerto Rico: university district hospital.

Báez Bonilla R, Parrilla F, Kidd O, Cangiano JL.

Bol Asoc Med P R. 2011 Jul-Sep;103(3):10-2.

PMID:
23210326
13.

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.

Heerspink HL, Greene T, Lewis JB, Raz I, Rohde RD, Hunsicker LG, Schwartz SL, Aronoff S, Katz MA, Eisner GM, Mersey JH, Wiegmann TB; Collaborative Study Group.

Nephrol Dial Transplant. 2008 Jun;23(6):1946-54. Epub 2007 Dec 18.

PMID:
18089623
14.

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.

Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK.

Kidney Int. 2007 Nov;72(9):1130-7. Epub 2007 Aug 29.

15.

Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial.

Singh H, Reed J, Noble S, Cangiano JL, Van Wyck DB; United States Iron Sucrose (Venofer) Clinical Trials Group.

Clin J Am Soc Nephrol. 2006 May;1(3):475-82. Epub 2006 Mar 29.

16.

Influence of Hispanic ethnicity on blood pressure control and cardiovascular outcomes in women with CAD and hypertension: findings from INVEST.

Cooper-DeHoff RM, Zhou Q, Gaxiola E, Cangiano JL, Garcia-Barreto D, Handberg E, Pepine CJ; INVEST Investigators.

J Womens Health (Larchmt). 2007 Jun;16(5):632-40.

PMID:
17627399
17.

Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).

Cooper-DeHoff RM, Aranda JM Jr, Gaxiola E, Cangiano JL, Garcia-Barreto D, Conti CR, Hewkin A, Pepine CJ; INVEST Investigators.

Am Heart J. 2006 May;151(5):1072-9.

PMID:
16644338
18.

Characteristics of contemporary patients with hypertension and coronary artery disease.

Cooper-DeHoff RM, Handberg EM, Cohen J, Kowey P, Messerli FH, Mancia G, Cangiano JL, Gaxiola E, Garcia-Barreto D, Hewkin AC, Pepine CJ; INVEST Investigators.

Clin Cardiol. 2004 Oct;27(10):571-6.

19.

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Pepine CJ, Handberg EM, Cooper-DeHoff RM, Marks RG, Kowey P, Messerli FH, Mancia G, Cangiano JL, Garcia-Barreto D, Keltai M, Erdine S, Bristol HA, Kolb HR, Bakris GL, Cohen JD, Parmley WW; INVEST Investigators.

JAMA. 2003 Dec 3;290(21):2805-16.

PMID:
14657064
20.

Hypertension and renal disease in Puerto Ricans.

Cangiano JL.

Am J Med Sci. 1999 Dec;318(6):369-73. Review.

PMID:
10616161

Supplemental Content

Loading ...
Support Center